The latest from the Proscia blog Unlocking a Critical Use Case in Pathology Cytology has always been one of the most technically demanding areas of pathology. Unlike histology, where tissue sections are relatively uniform, cytology samples...

The latest from the Proscia blog: Every diagnosis is based on data that can change the course of drug development and patient care. With the growing adoption of digital pathology, laboratories are now generating a wealth of tissue images...

The latest from the Indica Labs blog Overview: The Clinical Trials Module in HALO AP Platforms  The Clinical Trials module in HALO AP®, a CE-IVDR marked and AI-powered platform for primary diagnosis, and HALO AP Dx, an FDA-cleared...

From the Proscia blog: If you’re a diagnostic laboratory looking to go digital, then you’ve almost certainly thought about how your platform will integrate with your LIS. We sat down with Jacob Blaylock, our Senior Integration Engineer,...

The latest from the Proscia blog In a recent Today’s Clinical Lab webinar, our Chief Strategy Officer Nathan Buchbinder led a discussion on insights stemming from The 2025 Laboratory Leadership Report. He was joined by three of our...

The latest from the Proscia blog: Everyone’s talking about AI in therapeutic R&D, but it’s not always easy to cut through the hype to understand where it’s making a real impact today. One of the clearest signals of progress?...